Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease

  • Read more about Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease

A Study of S-892216 in Participants With COVID-19

  • Read more about A Study of S-892216 in Participants With COVID-19

Are Pediatric Patients' Dental Anxiety Levels Affected by Covid -19 Clinical Conditions?

  • Read more about Are Pediatric Patients' Dental Anxiety Levels Affected by Covid -19 Clinical Conditions?

Effect of Hi-OxSR for the Treatment of Post COVID Condition (RECLAIM-HiOxSR)

  • Read more about Effect of Hi-OxSR for the Treatment of Post COVID Condition (RECLAIM-HiOxSR)

Heat thErapy And mobiLity in COVID-19 Survivors

  • Read more about Heat thErapy And mobiLity in COVID-19 Survivors

Corona Virus Disease 2019 Cohort Study

  • Read more about Corona Virus Disease 2019 Cohort Study

Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere

  • Read more about Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere

Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.

  • Read more about Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in People With Long COVID-19.

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

  • Read more about Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

  • Read more about Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA